DRL to Sell Generic Version of Montelukast Sodium in US

by Kathy Jones on  September 28, 2012 at 7:41 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Hyderabad based pharmaceutical company Dr Reddy's Laboratories has announced that it has launched the generic version of its Montelukast Sodium oral granules in the United States after receiving approval from the US Food and Drug Administration.
 DRL to Sell Generic Version of Montelukast Sodium in US
DRL to Sell Generic Version of Montelukast Sodium in US

The granules are a bioequivalent generic version of Singulair and will be used in treating asthma and other seasonal allergies.

The company said that the granules will be available in 4mg strengths and will come in a pack of 30. Figures from IMS Health shows that Singulair oral granules accounted for annual sales of $61 million in the US market.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Hyponatremia Hypochloremia 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...